RVTY 📈 Revvity - Overview

Revvity, Inc. operates as a global provider of health sciences solutions, leveraging its extensive portfolio of technologies and services to cater to the diverse needs of the Americas, Europe, Asia, and international markets. The company's Life Sciences segment is a critical component of its operations, offering a wide range of products and services including instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies. Additionally, it provides warranties, training, and services to support its clients. This segment is designed to facilitate research, discovery, and development in the life sciences industry, enabling scientists and researchers to make groundbreaking discoveries and advancements.

The Diagnostics segment of Revvity, Inc. is focused on the development and provision of instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, infectious diseases, and other health conditions. Its products are utilized for testing and screening genetic abnormalities, disorders, and diseases such as down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also invests in the development of technologies that enable and support genomic workflows, including protein coupled receptor and next-generation DNA sequencing. These technologies have far-reaching applications in oncology, immunodiagnostics, and drug discovery, and are used by a broad range of clients including pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies.

Revvity, Inc.'s product portfolio is extensive and diverse, featuring a wide range of brand names including AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10, IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind, PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord, VICTOR 2D, and Zephyr. The company has a long history, dating back to 1937, and was formerly known as PerkinElmer, Inc. before changing its name to Revvity, Inc. in April 2023. Headquartered in Waltham, Massachusetts, Revvity, Inc. is a leading player in the life sciences industry, with a strong online presence at https://www.revvity.com and a common stock listed under the ISIN US7140461093, classified under the GICS Sub Industry: Life Sciences Tools & Services.